These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15828857)

  • 1. Practical guidelines to interpret plasma concentrations of antiretroviral drugs.
    Leith J; Hinzmann R; Mayers D
    Clin Pharmacokinet; 2005; 44(4):439; author reply 439-40. PubMed ID: 15828857
    [No Abstract]   [Full Text] [Related]  

  • 2. Practical guidelines to interpret plasma concentrations of antiretroviral drugs.
    Kappelhoff BS; Crommentuyn KM; de Maat MM; Mulder JW; Huitema AD; Beijnen JH
    Clin Pharmacokinet; 2004; 43(13):845-53. PubMed ID: 15509183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia.
    Ellis JC; L'homme RF; Ewings FM; Mulenga V; Bell F; Chileshe R; Molyneux E; Abernethy J; van Oosterhout JJ; Chintu C; Walker AS; Gibb DM; Burger DM
    Antivir Ther; 2007; 12(2):253-60. PubMed ID: 17503667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efavirenz and nevirapine in HIV-1 infection : is there a role for clinical pharmacokinetic monitoring?
    Dahri K; Ensom MH
    Clin Pharmacokinet; 2007; 46(2):109-32. PubMed ID: 17253884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of nevirapine plasma concentrations between lead-in and steady-state periods in Chinese HIV-infected patients.
    Kou H; Du X; Li Y; Xie J; Qiu Z; Ye M; Fu Q; Han Y; Zhu Z; Li T
    PLoS One; 2013; 8(1):e52950. PubMed ID: 23359265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nevirapine and efavirenz pharmacokinetics and covariate analysis in the 2NN study.
    Kappelhoff BS; van Leth F; MacGregor TR; Lange J; Beijnen JH; Huitema AD;
    Antivir Ther; 2005; 10(1):145-55. PubMed ID: 15751772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of nevirapine: once-daily versus twice-daily dosing in the 2NN study.
    Kappelhoff BS; Huitema AD; van Leth F; Robinson PA; MacGregor TR; Lange JM; Beijnen JH;
    HIV Clin Trials; 2005; 6(5):254-61. PubMed ID: 16306032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic of nevirapine in haemodialysis.
    Izzedine H; Launay-Vacher V; Aymard G; Legrand M; Deray G
    Nephrol Dial Transplant; 2001 Jan; 16(1):192-3. PubMed ID: 11209031
    [No Abstract]   [Full Text] [Related]  

  • 9. St. John's wort found to lower nevirapine levels.
    TreatmentUpdate; 2001; 12(11):6. PubMed ID: 11570073
    [No Abstract]   [Full Text] [Related]  

  • 10. Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Nevirapine levels in the blood found higher in women.
    TreatmentUpdate; 2003; 15(3):2. PubMed ID: 17216844
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission.
    Jackson JB; Parsons T; Musoke P; Nakabiito C; Donnell D; Fleming T; Mirochnick M; Mofenson L; Fowler MG; Mmiro F; Guay L
    AIDS; 2006 Jan; 20(2):217-22. PubMed ID: 16511414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing nevirapine dose can overcome reduced bioavailability due to rifampicin coadministration.
    Ramachandran G; Hemanthkumar AK; Rajasekaran S; Padmapriyadarsini C; Narendran G; Sukumar B; Sathishnarayan S; Raja K; Kumaraswami V; Swaminathan S
    J Acquir Immune Defic Syndr; 2006 May; 42(1):36-41. PubMed ID: 16639340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy for previously untreated HIV-1-infected adults: 2NN, or just one?
    Carr A
    Lancet; 2004 Apr; 363(9417):1248-50. PubMed ID: 15094265
    [No Abstract]   [Full Text] [Related]  

  • 14. Sex differences in nevirapine disposition in HIV-infected patients.
    Regazzi M; Villani P; Seminari E; Ravasi G; Cusato M; Marubbi F; Meneghetti G; Maserati R
    AIDS; 2003 Nov; 17(16):2399-400. PubMed ID: 14571195
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of concentration and temperature on the stability of nevirapine in whole blood and serum.
    Bennetto CJ; King JR; Turner ML; Stringer JS; Acosta EP
    Clin Chem; 2004 Jan; 50(1):209-11. PubMed ID: 14709651
    [No Abstract]   [Full Text] [Related]  

  • 16. Follow-up measurements of Nevirapine plasma levels over a prolonged period.
    Sienz M; Zilly M; Ebigbo A; Knipper A; Winzer R; Klinker H; Langmann P
    Eur J Med Res; 2004 Aug; 9(8):412-6. PubMed ID: 15337632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are plasma levels valid surrogates for cellular concentrations of antiretroviral drugs in HIV-infected patients?
    Colombo S; Telenti A; Buclin T; Furrer H; Lee BL; Biollaz J; Decosterd LA;
    Ther Drug Monit; 2006 Jun; 28(3):332-8. PubMed ID: 16778716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness also in general practice conditions. Just as good in routine practice as in studies].
    MMW Fortschr Med; 2000; 142(3 Suppl):36-7. PubMed ID: 10893965
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users.
    Clarke SM; Mulcahy FM; Tjia J; Reynolds HE; Gibbons SE; Barry MG; Back DJ
    Clin Infect Dis; 2001 Nov; 33(9):1595-7. PubMed ID: 11568856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-line and second-line antiretroviral therapy.
    Kulwichit W
    Lancet; 2004 Jul 24-30; 364(9431):329-30; author reply 330. PubMed ID: 15276389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.